Safety of the Use of Compressive Taping in Seroma

Only registered users can translate articles

The link is saved to the clipboard

StatusCompleted

Keywords

Abstract

Seroma is the most common complication at the beginning of healing after surgery for breast cancer treatment. Its incidence varies in the literature from 2.5 to 90% and is defined as a collection of serous fluid that develops through skin flaps in the dead space after mastectomy or axillary dissection. The physiopathology for seroma formation has not yet been fully understood, but appears to be multifactorial with surgery being the main factor. Although seroma formation is not a threat to life, it can lead to important morbidity due to associated with necrosis, dehiscence, predisposition to sepsis, reduction of shoulder functions due to muscle weakness due to restriction of movement, prolonging the recovery period and, consequently, leading to delay in adjuvant therapy. The best seroma treatment is still not well defined in the literature and the compressive therapy aims to rebalance fluid exchange between the lymphatic system and blood, having as effects the increase of the interstitial pressure, the improvement of the effectiveness of muscular work, increased resistance of the skin and prevention new collection of interstitial fluid. Recently, the Kinesio® Taping method were inserted into clinical practice for its ability to reduce pain and local swelling. Objective: To evaluate the safety of taping in the seroma after surgical treatment of breast cancer. Methodology: This is a pre and post-clinical application of taping on the seroma in women submitted to surgical treatment for breast cancer in the Cancer Hospital III / INCA. The intervention was performed by applying the compression bandage over the seroma region for an average of five days, when the reassessment was performed.

Description

Patients identified by the nursing team with seroma and with indication of aspiration puncture, will be evaluated for eligibility criteria. Those who agree to participate in the study will be assessed and submitted to the intervention on the same day, they will remain with four days approximately for nursing and physiotherapy revaluation for intervention suspension. The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® neuromuscular bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the fluctuation region (seroma) and finalized with another base without stretching, of 2 centimeters, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region. The bandage will not be applied on the scar. If there are any complications such as itching, redness, discomfort and / or others, the patients will remove the material at home and communicate on return to the institution. The interview will be conducted at the entrance to the study, prior to the intervention and the end of the study. In the initial interview will be collected sociodemographic data and life habits. They will be evaluated by questionnaire as the local symptoms caused by the use of the bandages, the tolerance and feeling / referred sensation during and at the end of intervention period, the percentage of seroma volume alteration before and after the use of the bandage, the number of days of use and bandage detachment. All reviews will be carried out by another professional who will not make the interventions. From the hospital record, information will be collected regarding the oncology treatment, histopathological report and clinical data on curative care.

Dates

Last Verified:	06/30/2018
First Submitted:	10/29/2017
Estimated Enrollment Submitted:	07/15/2018
First Posted:	07/17/2018
Last Update Submitted:	07/15/2018
Last Update Posted:	07/17/2018
Actual Study Start Date:	06/05/2017
Estimated Primary Completion Date:	08/28/2017
Estimated Study Completion Date:	09/18/2017

Condition or disease

Seroma

Intervention/treatment

Device: Intervention Vitaltape® bandage

Phase

Arm Groups

Arm	Intervention/treatment
Experimental: Intervention Vitaltape® bandage The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the seroma and finalized with another base no stretching, of 2 cm, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region. The bandage will not be applied on the scar. If there are any complications such as itching, redness, discomfort and / or others, the patients will remove the material at home and communicate on return to the institution. They will remain four days approximately for revaluation and intervention suspension.	Device: Intervention Vitaltape® bandage The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® neuromuscular bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the seroma and finalized with another base no stretching, of 2 cm, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region.

Arm

Intervention/treatment

Experimental: Intervention Vitaltape® bandage

The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the seroma and finalized with another base no stretching, of 2 cm, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region. The bandage will not be applied on the scar. If there are any complications such as itching, redness, discomfort and / or others, the patients will remove the material at home and communicate on return to the institution. They will remain four days approximately for revaluation and intervention suspension.

Device: Intervention Vitaltape® bandage

The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® neuromuscular bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the seroma and finalized with another base no stretching, of 2 cm, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region.

Eligibility Criteria

Sexes Eligible for Study

Female

Accepts Healthy Volunteers

Yes

Criteria

Inclusion Criteria:

- Women who developed seroma after surgical treatment for breast cancer, detected by nursing team.

Exclusion Criteria:

- bilateral breast cancer

- neoadjuvant radiotherapy

- wound infection

- reporting of autoimmune diseases (dermatomyositis, hidradenitis suppurativa, nephropathy, lupus erythematosus, morphea, psoriasis, pemphigus vulgaris, scleroderma)

- patients with difficulties of understanding.

Outcome

Primary Outcome Measures

1. To evaluate the safety of compressive taping in the treatment of seroma [3 months]

Dermal changes were evaluated at the site of application of the bandage of the 35 participants, such as discoloration, local temperature increase, skin peeling, presence of wound and formation of bullous lesions at the site of application of neuromuscular bandage, graded in mild, moderate or severe , according to the severity of the change, from a semi-structured questionnaire.

Secondary Outcome Measures

1. Bandage dettachment [3 months]

It will be observed at revaluation and at what time the detachment occurred

2. Seroma volume difference [3 months]

It will be made from the comparison between the volumes of liquid punctured by the nursing team on the day of application and on the return of the patient

3. to assess the tolerance reported by the patient to the use of compressive taping [3 months]

The sensation of pain, pruritus, burning, discomfort, tightness, increased fluctuation (seroma) at the application site of all 35 participants were evaluated. The symptoms were graded according to the Visual Numerical Scale (0-10), where 0 was considered no sensation and 10 unbearable sensation with the use of the bandage.

4. to assess the satisfaction reported by the patient to the use of compressive taping [3 months]

The satisfaction reported by the 35 participants with the use of the bandage was evaluated, being graded according to the Visual Numerical Scale, where 0 was considered totally dissatisfied and 10 totally satisfied.

5. to assess the safety reported by the patient to the use of compressive [3 months]

The safety referred by the 35 participants with the use of the bandage was evaluated, being graded according to the Visual Numerical Scale, where 0 was considered totally unsafe and 10 totally safe.

Safety of the Use of Compressive Taping in Seroma

Keywords

breast neoplasms

sepsis

neoplasms

asthenia

seroma

necrosis

erythema

muscle weakness

anticancer

Abstract

Description

Dates

Condition or disease

Intervention/treatment

Phase

Arm Groups

Eligibility Criteria

Outcome

The most complete medicinal herbs database backed by science